Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-005398
Filing Date
2020-06-17
Accepted
2020-06-17 15:14:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27619
2 filename2.txt TEXT-EXTRACT 1400
  Complete submission text file 0000000000-20-005398.txt   40061
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filed for) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations